Diagnostic Laboratory Agrees to Pay More Than $1 Million to Settle Alleged False Claims Act Violations

Baltimore, Maryland – Genetic Technological Innovations, LLC (GTI), a diagnostic laboratory headquartered in Scottsdale, Arizona, agreed to pay the United States $1.635 million to resolve allegations that it violated the False Claims Act and the Anti-Kickback Statute (AKS). Kelly O. Hayes, U.S. Attorney for the District of Maryland, announced the settlement with Special Agent in Charge Maureen Dixon, Department of Health and Human Services Office of Inspector General (HHS-OIG). The government alleges that GTI knowingly submitted claims to Medicare for respiratory pathogen panels (RPPs) that were either medically unnecessary or obtained through kickbacks.

Read more on www.justice.gov